OPRX
OptimizeRx Corporation NASDAQ Listed Nov 28, 2007$6.64
Mkt Cap $124.6M
52w Low $5.54
6.6% of range
52w High $22.25
50d MA $6.68
200d MA $13.02
P/E (TTM)
23.9x
EV/EBITDA
14.0x
P/B
1.0x
Debt/Equity
0.2x
ROE
4.0%
P/FCF
12.2x
RSI (14)
—
ATR (14)
—
Beta
1.28
50d MA
$6.68
200d MA
$13.02
Avg Volume
502.3K
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
400 Water Street · Waltham, MI 48307 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | AMC | 0.23 | 0.51 | +121.7% | 7.53 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% | — |
| Nov 6, 2025 | AMC | 0.03 | 0.20 | +566.7% | 18.94 | -4.6% | -17.4% | -12.8% | -16.1% | -14.7% | -18.4% | — |
| Aug 7, 2025 | AMC | 0.03 | 0.24 | +700.0% | 12.84 | +26.6% | +34.7% | +26.0% | +27.7% | +35.0% | +37.0% | — |
| May 12, 2025 | AMC | -0.11 | 0.08 | +172.7% | 9.20 | +25.0% | +19.7% | +9.9% | +15.8% | +24.2% | +32.6% | — |
| Mar 12, 2025 | AMC | 0.25 | 0.30 | +20.0% | 6.28 | +0.8% | +13.9% | +23.7% | +31.7% | +43.6% | +37.1% | — |
| Nov 13, 2024 | AMC | 0.06 | 0.12 | +100.0% | 6.15 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% | — |
| Aug 8, 2024 | AMC | -0.07 | 0.02 | +128.6% | 8.85 | -0.1% | -5.3% | -5.8% | -2.3% | -5.5% | -5.1% | — |
| May 14, 2024 | AMC | -0.11 | -0.11 | +0.0% | 10.48 | +33.1% | +25.7% | +22.6% | +21.1% | +24.8% | +23.0% | — |
| Mar 28, 2024 | AMC | 0.32 | 0.26 | -18.8% | 12.15 | +0.7% | -6.0% | -7.6% | -8.1% | -7.7% | -6.4% | — |
| Nov 6, 2023 | AMC | 0.03 | 0.09 | +260.0% | 9.79 | +0.9% | -1.2% | -5.9% | -8.1% | -6.8% | -9.5% | — |
| Aug 14, 2023 | AMC | -0.01 | -0.01 | -53.7% | 12.57 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% | — |
| May 10, 2023 | AMC | -0.08 | -0.09 | -12.5% | 14.28 | -2.3% | -5.5% | -8.8% | -8.4% | -12.6% | -14.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $7.53 | $6.90 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% |
| Mar 6 | Roth Capital | Maintains | Buy → Buy | — | $7.53 | $6.90 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% |
| Mar 6 | Lake Street | Maintains | Buy → Buy | — | $7.53 | $6.90 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% |
| Mar 6 | Stifel | Maintains | Buy → Buy | — | $7.53 | $6.90 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% |
| Mar 6 | B. Riley Securities | Maintains | Buy → Buy | — | $7.53 | $6.90 | -8.4% | -10.5% | -9.2% | -12.6% | -11.4% | -21.2% |
| Nov 17 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $15.18 | $14.87 | -2.0% | -2.6% | -7.0% | -6.1% | -10.5% | -3.9% |
| Nov 7 | Citizens | Maintains | Market Outperform → Market Outperform | — | $18.94 | $18.06 | -4.6% | -17.4% | -12.8% | -16.1% | -14.7% | -18.4% |
| Oct 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $18.29 | $18.91 | +3.4% | -1.1% | +2.4% | +8.8% | +11.5% | +8.1% |
| Aug 11 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $17.30 | $17.43 | +0.8% | -6.5% | -5.2% | +0.2% | +1.7% | -2.5% |
| Aug 8 | Stifel | Maintains | Buy → Buy | — | $12.84 | $16.25 | +26.6% | +34.7% | +26.0% | +27.7% | +35.0% | +37.0% |
| Jun 9 | Stifel | Maintains | Buy → Buy | — | $14.62 | $15.06 | +3.0% | +1.0% | +5.6% | +4.0% | +2.9% | -2.4% |
| May 13 | Stifel | Maintains | Buy → Buy | — | $9.20 | $11.50 | +25.0% | +19.7% | +9.9% | +15.8% | +24.2% | +32.6% |
| May 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $9.20 | $11.50 | +25.0% | +19.7% | +9.9% | +15.8% | +24.2% | +32.6% |
| Feb 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $5.67 | $5.64 | -0.5% | -2.8% | -2.6% | -0.2% | -1.2% | -1.4% |
| Jan 8 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $5.82 | $5.49 | -5.7% | -7.0% | -7.9% | -16.7% | -16.3% | -15.1% |
| Dec 24 | B. Riley Securities | Maintains | Buy → Buy | — | $4.83 | $5.02 | +3.9% | +2.3% | +7.0% | +5.4% | +9.3% | +0.6% |
| Dec 24 | Lake Street | Maintains | Buy → Buy | — | $4.83 | $5.02 | +3.9% | +2.3% | +7.0% | +5.4% | +9.3% | +0.6% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $6.15 | $4.75 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% |
| Nov 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $6.15 | $4.75 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% |
| Nov 14 | Roth MKM | Maintains | Buy → Buy | — | $6.15 | $4.75 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% |
| Nov 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $6.15 | $4.75 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% |
| Nov 14 | Stifel | Maintains | Buy → Buy | — | $6.15 | $4.75 | -22.8% | -34.0% | -37.7% | -31.7% | -33.7% | -28.1% |
| Aug 16 | RBC Capital | Maintains | Outperform → Outperform | — | $8.40 | $8.39 | -0.1% | -0.7% | +0.6% | +0.4% | +1.9% | -1.1% |
| Aug 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $8.38 | $8.20 | -2.1% | -0.5% | +3.2% | -0.2% | +0.2% | -0.5% |
| Jun 24 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.57 | $10.59 | +0.2% | -1.8% | -3.4% | -2.8% | -2.4% | -5.4% |
| Jun 21 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.73 | $10.73 | +0.0% | -1.5% | -3.3% | -4.8% | -4.3% | -3.8% |
| May 15 | Stifel | Maintains | Buy → Buy | — | $10.48 | $13.95 | +33.1% | +25.7% | +22.6% | +21.1% | +24.8% | +23.0% |
| May 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.48 | $13.95 | +33.1% | +25.7% | +22.6% | +21.1% | +24.8% | +23.0% |
| Apr 16 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $10.32 | $11.02 | +6.8% | -3.5% | -7.7% | -9.4% | -9.7% | -11.9% |
| Apr 1 | Stifel | Maintains | Buy → Buy | — | $12.15 | $12.23 | +0.7% | -6.0% | -7.6% | -8.1% | -7.7% | -6.4% |
| Apr 1 | RBC Capital | Maintains | Outperform → Outperform | — | $12.15 | $12.23 | +0.7% | -6.0% | -7.6% | -8.1% | -7.7% | -6.4% |
| Jan 10 | RBC Capital | Maintains | Outperform → Outperform | — | $15.21 | $15.11 | -0.7% | -2.4% | -1.8% | -2.8% | -2.2% | -0.1% |
| Aug 15 | Roth MKM | Maintains | Buy → Buy | — | $12.57 | $8.76 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% |
| Aug 15 | B. Riley Securities | Maintains | Buy → Buy | — | $12.57 | $8.76 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% |
| Aug 15 | RBC Capital | Maintains | Outperform → Outperform | — | $12.57 | $8.76 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% |
| Aug 15 | Lake Street | Maintains | Buy → Buy | — | $12.57 | $8.76 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% |
| Aug 15 | Stifel | Maintains | Buy → Buy | — | $12.57 | $8.76 | -30.3% | -27.8% | -29.0% | -28.2% | -31.1% | -36.4% |
| Mar 9 | RBC Capital | Maintains | Outperform → Outperform | — | $16.24 | $14.25 | -12.3% | -11.6% | -19.4% | -22.8% | -17.2% | -20.3% |
| Nov 1 | Stifel | Maintains | Buy → Buy | — | $15.42 | $16.34 | +6.0% | -0.8% | -4.2% | -8.3% | -8.2% | -5.7% |
| Oct 31 | Stifel | Maintains | Buy → Buy | — | $15.47 | $15.35 | -0.8% | -0.3% | -1.1% | -4.5% | -8.6% | -8.5% |
| Aug 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $22.25 | $13.80 | -38.0% | -30.0% | -28.4% | -26.9% | -29.9% | -29.0% |
| Aug 10 | RBC Capital | Maintains | Outperform → Outperform | — | $22.25 | $13.80 | -38.0% | -30.0% | -28.4% | -26.9% | -29.9% | -29.0% |
| Aug 10 | Piper Sandler | Maintains | Neutral → Neutral | — | $22.25 | $13.80 | -38.0% | -30.0% | -28.4% | -26.9% | -29.9% | -29.0% |
| Jul 20 | B. Riley Securities | Maintains | Buy → Buy | — | $29.92 | $28.31 | -5.4% | -17.6% | -18.6% | -31.3% | -29.5% | -23.8% |
| Jul 15 | SVB Leerink | Maintains | Outperform → Outperform | — | $27.94 | $29.52 | +5.7% | +5.1% | +3.0% | +7.1% | -11.8% | -12.8% |
| Jul 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $27.39 | $27.19 | -0.7% | +1.6% | +5.6% | +7.5% | +9.9% | +10.0% |
| May 5 | RBC Capital | Maintains | Outperform → Outperform | — | $29.97 | $30.75 | +2.6% | -6.5% | -15.3% | -21.0% | -20.3% | -26.8% |
| May 5 | Roth Capital | Maintains | Buy → Buy | — | $29.97 | $30.75 | +2.6% | -6.5% | -15.3% | -21.0% | -20.3% | -26.8% |
| Feb 16 | Lake Street | Maintains | Buy → Buy | — | $48.63 | $48.02 | -1.3% | +0.9% | -7.5% | -9.6% | -14.4% | -18.5% |
| Nov 10 | RBC Capital | Maintains | Outperform → Outperform | — | $85.84 | $88.25 | +2.8% | -0.0% | -3.8% | +1.6% | -6.7% | -9.0% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of an executive effective April 14, 2026 creates near-term leadership uncertainty and potential strategy disruption, which could pressure these small-cap stocks until succession clarity emerges.
Apr 16
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
I cannot provide a specific analysis without seeing the actual press release content in Exhibit 99.1, which details the executive change at Oppenheimer Pharmaceuticals (OPRX).
Apr 9
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
OPRX's auditor change to Grant Thornton suggests potential accounting disputes or cost considerations with the previous firm, warranting investor scrutiny of any qualification statements or accounting policy shifts.
Mar 30
8-K · 8.01
!! High
OptimizeRx Corporation -- 8-K 8.01: Material Event / Announcement
OptimizeRx authorized a $10 million share buyback program, signaling management confidence in valuation while providing potential support for the stock price through opportunistic repurchases.
Mar 5
Data updated apr 26, 2026 5:42pm
· Source: massive.com